Lucid Diagnostics And Subsidiary Of PAVmed Announced That It Has Submitted Its Complete Clinical Evidence Package For Its Esoguard Esophageal DNA Test To Molecular Diagnostics Program Seeking Medicare Coverage For Esoguard Esophageal DNA Test
Lucid Diagnostics And Subsidiary Of PAVmed Announced That It Has Submitted Its Complete Clinical Evidence Package For Its Esoguard Esophageal DNA Test To Molecular Diagnostics Program Seeking Medicare Coverage For Esoguard Esophageal DNA Test
Lucid Diagnostics和pavmed的子公司宣佈已經提交了完整的臨床證據包，用於其Esoguard食道DNA檢測，旨在爭取Medicare對Esoguard食道DNA檢測的醫療保險覆蓋
Lucid Diagnostics And Subsidiary Of PAVmed Announced That It Has Submitted Its Complete Clinical Evidence Package For Its Esoguard Esophageal DNA Test To Molecular Diagnostics Program Seeking Medicare Coverage For Esoguard Esophageal DNA Test
Lucid Diagnostics和pavmed的子公司宣佈已經提交了完整的臨床證據包，用於其Esoguard食道DNA檢測，旨在爭取Medicare對Esoguard食道DNA檢測的醫療保險覆蓋
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間